rhinitis%20-%20nonallergic%20(pediatric)
RHINITIS - NONALLERGIC (PEDIATRIC)
Rhinitis is the inflammation of the nasal lining membranes.
Nonallergic rhinitis is a diagnosis of rhinitis without any immunoglobulin E (IgE) mediation, as documented by allergen skin testing.
Signs & symptoms are nasal itching, rhinorrhea, nasal congestion with or without obstruction and sneezing.

Principles of Therapy

  • If possible, treatment should be aimed at the underlying causative physiology of nonallergic rhinitis
  • Treatment response may be less effective than in allergic rhinitis
  • Predominantly aimed at symptomatic treatment
  • Medications may be administered on an “as-required” basis or as a long-term therapy

Pharmacotherapy

Anticholinergics
  • Action: Inhibit the parasympathetic nervous system that innervates the serous & seromucous glands
  • Ideal for patients who present only with rhinorrhea, especially in gustatory rhinitis
  • Have no activity against sneezing, itching or nasal congestion
Antihistamines
  • Less effective in nasal congestion but some have anti-inflammatory properties
Nasal Antihistamines
  • Effect: Have been shown to control rhinorrhea
  • Effective for vasomotor rhinitis
Oral Antihistamines
  • 1st generation antihistamines may be useful in controlling rhinorrhea
  • Generally less effective for nonallergic rhinitis but may be used as an adjuvant to nasal corticosteroids in the treatment of NARES
Corticosteroids (Nasal)
  • Effect: Decrease nasal obstruction
  • Onset of action is relatively slow (up to 4 weeks) with maximum efficacy after a few days, thus more recommended for patients with chronic symptoms
  • Patient should be maintained on the lowest effective dose
  • Caution is needed due to the possible effect on growth
  • Regular height measurements are advised
Decongestants
  • Preparations containing Ephedrine, Oxymetazoline & Xylometazoline should not be used in patients <2 years of age
Nasal Decongestants
  • Relieves nasal obstruction & postnasal drainage
Oral Decongestants
  • Effects: Relieve nasal obstruction & postnasal drainage
  • Ideal for long-term use & for patients with sporadic symptoms
  • Do not cause rebound nasal congestion
  • May be used in combination with nasal corticosteroids
  • May cause CNS stimulation, hypertension & cardiac arrhythmias
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 5 days ago

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

Stephen Padilla, 6 days ago
Early administration of recombinant human B-type natriuretic peptide (rhBNP) can lower the incidence of reperfusion injury for patients with ST-elevation myocardial infarction (STEMI) who are receiving percutaneous coronary intervention (PCI) treatment, according to a China study.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
3 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.